Twenty one months into an unrelenting pandemic and we are entering another unprecedented period. The exponential increase and […]

Researchers developed a new, faster, less expensive method for screening billions of chemical compounds to find new, targeted […]

Artificial intelligence can predict which people who attend memory clinics will develop dementia within two years with 92 […]

Researchers in the UK and China have developed an artificial intelligence (AI) model that can diagnose COVID-19 as […]

Being precautionaryDiscussing therapeutic interventions a couple of weeks ago,1 I invoked the benefit:harm balance, and suggested three different […]

Back in February 2021, the UK government announced that £18.5m is being invested into clinical research into long […]

Over the past few decades the argument for the need for diversification within the surgical field has been […]

The government has committed “in principle” to creating a public repository of consultants’ practice details that sets out […]

Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pact aliu Fri, 12/17/2021 – […]

Inozyme rebrand shows the biopharma in a fresher, purple light sharon.coey Fri, 12/17/2021 – 06:26